Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02518958
Title A Phase I, Open-Label, Multiple Ascending Dose Study of RRx-001 and Nivolumab
Acronym PRIMETIME
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors EpicentRx, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Walter Reed National Military Medical Center Bethesda Maryland 20889 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field